Clinical Trial Update: Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Cancer

View source ↗

Summary

A completed clinical trial evaluating Circulating Tumour Cells as biomarkers to predict metastasis in prostate cancer and guide treatment stratification.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Queen Mary University of London | Conditions: Prostate Cancer | Status: COMPLETED